2.The Lancet Diabetes & Endocrinology. Alarming rise in young-onset type 2 diabetes. Lancet Diabetes Endocrinol 2024;12:433.
6.Korean Diabetes AssociationDiabetes fact sheet in Korea 2022. Seoul: Korean Diabetes Association; 2023.
9.Emerging Risk Factors Collaboration. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. Lancet Diabetes Endocrinol 2023;11:731-42.
10.Misra S, Ke C, Srinivasan S, Goyal A, Nyriyenda MJ, Florez JC, et al. Current insights and emerging trends in early-onset type 2 diabetes. Lancet Diabetes Endocrinol 2023;11:768-82.
11.Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, et al. 2023 clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association. Diabetes Metab J 2023;47:575-94.
13.Shield JP, Lynn R, Wan KC, Haines L, Barrett TG. Management and 1 year outcome for UK children with type 2 diabetes. Arch Dis Child 2009;94:206-9.
15.Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, clus-terrandomised trial. Lancet Diabetes Endocrinol 2019;7:344-55.
17.Taheri S, Zaghloul H, Chagoury O, Elhadad S, Ahmed SH, El Khatib N, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2020;8:477-89.
20.Chan JCN, Paldánius PM, Mathieu C, Stumvoll M, Mat-thews DR, Del Prato S. Early combination therapy de-layed treatment escalation in newly diagnosed young-onset type 2 diabetes: a subanalysis of the VERIFY study. Diabetes Obes Metab 2021;23:245-51.
21.Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frim-er-Larsen H, Hafez M, Hale PM, et al; Ellipse Trial Investigators. Liraglutide in children and adolescents with type 2 diabetes. N Engl J Med 2019;381:637-46.
22.Arslanian SA, Hannon T, Zeitler P, Chao LC, Bouch-er-Berry C, Barrientos-Pérez M, et al; AWARD-PEDS Investigators. Once-weekly dulaglutide for the treatment of youths with type 2 diabetes. N Engl J Med 2022;387:433-43.
23.Tamborlane WV, Laffel LM, Shehadeh N, Isganaitis E, Van Name M, Ratnayake J, et al. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. Lancet Diabetes Endocrinol 2022;10:341-50.